A Modern Approach to Parasite PreventionMarch 15, 2025With evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Are Your Patients Fully Protected?March 15, 2025Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection.
Your Parasite Protection Recommendation, SimplifiedMarch 15, 2025Managing parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats.
Start Treating Canine MMVD Patients at Stage B2March 4, 2025Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients.
A new way to offer multi-organ supportFebruary 1, 2025NEW Hill's Prescription Diet Multi-Organ offers therapeutic nutrition for pets that may have conflicting nutritional needs.
Support patients' cognitive function and mobility.February 1, 2025Cognitive and mobility decline are common issues facing aging pets, and new Hill's Prescription Diet Brain Care + j/d can help.
Protect your patients from the start.February 1, 2025Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection.
Current users report reduced stress for parvovirus care1January 24, 2025Research shows that our Canine Parvovirus Monoclonal Antibody can help veterinary care teams work with less stress.1 Learn what CPMA can do for your parvo protocol.
A brighter future for parvovirus patientsJanuary 24, 2025Our Canine Parvovirus Monoclonal Antibody helps puppies recover faster, and current users report reductions in clinic stress during parvo treatment.1,2 Find out why veterinary teams are embracing CPMA.
Life-saving results for parvovirus casesJanuary 24, 2025Research has shown that puppies treated with our Canine Parvovirus Monoclonal Antibody have shorter clinic stays.1 Transform parvo treatment outcomes for your patients.